TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients (Q46691516)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients |
scientific article |
Statements
1 reference
TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients (English)
1 reference
A Tefferi
1 reference
T L Lasho
1 reference
J D Hood
1 reference
S Verstovsek
1 reference
D G Gilliland
1 reference
A Pardanani
1 reference
20 March 2008
1 reference
1 reference
22
1 reference
9
1 reference
1790-1792
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference